MAOA and sudden infant death syndrome: Considering that SIDS has been reported to be associated with abnormalities of neurotransmitter systems, MAOA promoter polymorphism, which could regulate the levels of serotonin and noradrenalin, is considered to be of great potential to be correlated with the risk of SIDS.